Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Heart Rhythm
- Epidemiology of cardiac implantable electronic device infections in the United States: a population-based cohort study.Heart Rhythm. 2020; 17: 1125-1131
- Treatment patterns, costs, and mortality among Medicare beneficiaries with CIED infection.Pacing Clin Electrophysiol. 2018; 41: 495-503
- Mortality and cost associated with cardiovascular implantable electronic device infections.Arch Intern Med. 2011; 171: 1821-1828
- Long-term mortality after transvenous lead extraction.Circ Arrhythm Electrophysiol. 2012; 5: 252-257
- Infected cardiac-implantable electronic devices: prevention, diagnosis, and treatment.Eur Heart J. 2015; 36: 2484-2490
- 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.Heart Rhythm. 2017; 14: e503-e551
- Modified temporary cardiac pacing using transvenous active fixation leads and external re-sterilized pulse generators.J Am Coll Cardiol. 2006; 47: 1487-1489
- Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study.Heart. 2012; 98: 724-731
- Five-year experience with temporary pacemaker therapy in the coronary care unit.Mayo Clin Proc. 1983; 58: 122-126
- Analysis of pacemaker malfunction and complications of temporary pacing in the coronary care unit.Am J Cardiol. 1982; 49: 301-306
- Temporary active fixation lead pacemaker in transcatheter aortic valve replacement patients with right bundle branch block.Heart Rhythm. 2023; 20: 309-310
- A review of temporary permanent pacemakers and a comparison with conventional temporary pacemakers.J Innov Card Rhythm Manag. 2019; 10: 3652-3661
- Updated performance of the Micra transcatheter pacemaker in the real-world setting: a comparison to the investigational study and a transvenous historical control.Heart Rhythm. 2018; 15: 1800-1807
- Concomitant leadless pacemaker implantation and lead extraction during an active infection.J Cardiovasc Electrophysiol. 2020; 31: 860-867
- Leadless cardiac pacemaker implantation after lead extraction in patients with severe device infection.J Cardiovasc Electrophysiol. 2016; 27: 1067-1071
- Percutaneous lead implantation connected to an external device in stimulation-dependent patients with systemic infection—a prospective and controlled study.Pacing Clin Electrophysiol. 2006; 29: 875-879
- Utility and cost effectiveness of temporary pacing using active fixation leads and an externally placed reusable permanent pacemaker.Am J Cardiol. 2006; 98: 1613-1615
- Utility and safety of temporary pacing using active fixation leads and externalized re-usable permanent pacemakers after lead extraction.Europace. 2013; 15: 1287-1291
- Utility and safety of prolonged temporary transvenous pacing using an active-fixation lead: comparison with a conventional lead.Pacing Clin Electrophysiol. 2003; 26: 1245-1248
- Usefulness of a new active-fixation lead in transvenous temporary pacing from the femoral approach.Pacing Clin Electrophysiol. 2003; 26: 849-852
- Incidence and outcomes of systemic infections in patients with leadless pacemakers: data from the Micra IDE study.Pacing Clin Electrophysiol. 2019; 42: 1105-1110
- Leadless pacemaker implantation after explantation of infected conventional pacemaker systems: a viable solution?.Heart Rhythm. 2019; 16: 66-71
- Leadless pacemaker implant in patients with pre-existing infections: results from the Micra postapproval registry.J Cardiovasc Electrophysiol. 2019; 30: 569-574
- Bacteraemia after leadless pacemaker implantation.J Cardiovasc Electrophysiol. 2020; 31: 2440-2447
- Retrieval of an infected leadless pacemaker.HeartRhythm Case Rep. 2020; 6: 863-866
- Treating an infected transcatheter pacemaker system via percutaneous extraction.HeartRhythm Case Rep. 2016; 2: 360-362
- Simultaneous infection of abandoned leads and newly implanted leadless cardiac pacemaker: why did this occur?.J Cardiol Cases. 2021; 23: 35-37
- Leadless pacemakers reduce risk of device-related infection: review of the potential mechanisms.Heart Rhythm. 2020; 17: 1393-1397
- Comparison of leadless pacing and temporary externalized pacing following cardiac implanted device extraction.J Innov Card Rhythm Manag. 2019; 10: 3930-3936
Mitacchione G, Schiavone M, Gasperetti A, et al. Outcomes of leadless pacemaker implantation following transvenous lead extraction in high-volume referral centers: real-world data from a large international registry [published online ahead of print December 7, 2022]. Heart Rhythm. doi:10.1016/j.hrthm.2022.12.002.
- Risk factors for repeat infection and mortality after extraction of infected cardiovascular implantable electronic devices.JACC Clin Electrophysiol. 2021; 7: 1182-1192
- Causes of early mortality after transvenous lead removal.JACC Clin Electrophysiol. 2022; 8: 1566-1575
- A worldwide experience of the management of battery failures and chronic device retrieval of the Nanostim leadless pacemaker.Heart Rhythm. 2017; 14: 1756-1763
- Risk factors for mortality in cardiac implantable electronic device (CIED) infections: a systematic review and meta-analysis.J Clin Med. 2022; 11: 3063
Publication stageIn Press Journal Pre-Proof
Funding Sources: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Disclosures: The authors have no conflicts of interest to disclose.
ScienceDirectAccess this article on ScienceDirect
- Leadless pacing in patients undergoing transvenous lead extraction due to infection: A small step in a long journeyHeart Rhythm
- PreviewImprovement in technology and expansion of indications have led to a progressive increase in the implantation of cardiovascular implantable electrical devices (CIED). This trend is accompanied by a rise in CIED-related complications, particularly device-related infections (DRIs), which are associated with a significant impact on patient prognosis and health care–associated costs.1,2 In the case of DRI, current guidelines give a class I indication to complete system removal using a transvenous lead extraction (TLE) approach.